Implementation of the Biosimilar Pathway: Economic and Policy Issues
dc.contributor.author | Grabowski, Henry | |
dc.contributor.author | Long, Genia | |
dc.contributor.author | Mortimer, Richard | |
dc.date.accessioned | 2013-04-23T16:19:28Z | |
dc.date.issued | 2011 | |
dc.identifier.uri | https://hdl.handle.net/10161/6702 | |
dc.relation.ispartof | Seton Hall Law Review | |
dc.title | Implementation of the Biosimilar Pathway: Economic and Policy Issues | |
dc.type | Journal article | |
pubs.begin-page | 511 | |
pubs.end-page | 557 | |
pubs.issue | 2 | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Economics | |
pubs.organisational-group | Trinity College of Arts & Sciences | |
pubs.publication-status | Published | |
pubs.volume | 41 |
Files in this item
This item appears in the following Collection(s)
- Scholarly Articles
Articles